Elevating the Role of Cardiologists in Diabetes Care: Cardiovascular Risk Reduction Strategies With GLP-1 Receptor Agonists

Join us for an interactive presentation where leading experts provide insight on strategies to reduce ASCVD risk in cardiology patients through the utilization of diabetes medications. Learn about GLP-1 receptor agonists, their role in cardiovascular risk reduction, and methods for implementing these agents into your practice.

Share

Program Content

No activities added yet

No activities added yet

No activities added yet

No activities added yet

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

This activity is supported by an educational grant from Novo Nordisk.

Novo Nordisk